ArticleCancer biology & therapy2011

Sorafenib attenuates p21 in kidney cancer cells and augments cell death in combination with DNA-damaging chemotherapy.

Hiromi Inoue et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.